HCM
UTHR icon

HMS Capital Management’s United Therapeutics UTHR Stock Holding History

HMS Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682K Sell
1,258
-64
-5% -$36K 0.25% 71
2026
Q1 		$784K Buy
1,322
+59
+5% +$29.4K 0.3% 62
2025
Q4 		$615K Sell
1,263
-11
-0.9% -$5.12K 0.25% 63
2025
Q3 		$534K Hold
1,274
– – 0.22% 70
2025
Q2 		$366K Sell
1,274
-42
-3% -$12.6K 0.16% 89
2025
Q1 		$384K Sell
1,316
-12
-0.9% -$4.11K 0.21% 77
2024
Q4 		$469K Sell
1,328
-3
-0.2% -$1.1K 0.23% 77
2024
Q3 		$477K Buy
+1,331
New +$450K 0.23% 71

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

HMS Capital Management's UTHR Position: Q2 2026 in Review

HMS Capital Management reduced its United Therapeutics (UTHR) stake by 4.8% in Q2 2026, selling an estimated $36K and leaving 1,258 shares worth $682K. The position accounts for 0.25% of the portfolio, ranked #71.

HMS Capital Management first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $784K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • HMS Capital Management held 1,258 shares of United Therapeutics worth $682K as of Q2 2026.
  • HMS Capital Management sold 64 United Therapeutics shares in Q2 2026, an estimated $36K.
  • United Therapeutics made up 0.25% of HMS Capital Management's portfolio in Q2 2026, its #71 holding.
  • HMS Capital Management first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • HMS Capital Management's United Therapeutics position peaked at $784K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on HMS Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.